Abstract:Objective To investigate the relationship between serum plasma brain natriuretic peptide ( BNP ) levels and myocardial injury in neoborns after asphyxia. Methods Neoborns who were admitted to Department of neonatology, Zhongnan Hospital, Wuhan University from December 2012 to December 2013 within 3 days after birth were considered. According to the number organized in chronological order every other case, newborns with neonatal asphyxia were assigned to observation group. The observation group were further divided into myocardial injury subgroup and non-cardiac injury subgroup according to the diagnostic criteria of myocardial injury. Newborns without neonatal asphyxia or neonatal cardiovascular diseases were assigned to control group. Exclusion criteria for control group were electrolyte disturbance, liver and kidney dysfunction. Blood sample was drawn from patients within 2 hours of admission to hospital and again on day 14. Serum BNP , creatine kinase isoenzyme ( CK-MB) , serum sodium and calcium were detected for further analysis. Results In 107 cases with neonatal asphyxia, 77 infants who had complete clinical records were selected as observation group, of which 36 met the diagnostic criteria of myocardial injury and assigned to myocardial injury subgroup. Non-cardiac injury subgroup consisted of the rest 41 cases in observation group. Twenty-two cases were enrolled to control group. Within 2 hours after admission, the serum BNP level of myocardial injury subgroup were significantly higher than those of the non-cardiac injury subgroup and the control group ( 2. 35 ± 0. 44 , 2. 12±0. 64, 1. 88±0. 27, log transformed, respectively, P＜0. 05). The BNP level of non-cardiac injury subgroup were also significantly higher than those of the control group. Serum BNP and CK-MB levels of observation group were positively correlated (r=0. 212,P=0. 030). After treatment, serum BNP level of myocardial injury subgroup at 14 days after admission decreased significantly, compared to the level at 2 hours within admission (P＜0. 05). When the cutoff value for infants with myocardial injury was 108. 05 pg/mL, the area under the ROC curve was 0. 753, with a sensitivity of 75. 0％ and a specificity of 64. 5％, positive predictive value was 56. 4％ and negative predictive value was 72. 3％. Conclusions Serum BNP level can reflect myocardial injury in neonates with asphyxia and can guide clinical treatment.

Study of serum NT-proBNP levels and warning mechanism in common diseases of neonates

Correlation Between Asphyxia Degree and the Level of Serum BNP and NT-proBNP After Asphyxia

N-Terminal Pro-B-Type Natriuretic Peptide As a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis.

The Value of Plasma N-Terminal Pro-Brain Natriuretic Peptide in the Evaluation of Heart Failure after Neonatal Asphyxia

Clinical value of serum brain natriuretic peptide levels and N-terminal pronatriuretic peptide levels in myocardial injury in neonates after asphyxia

Serum N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Critical Pulmonary Stenosis in Neonates

Study on the Level Changes of N-terminal Pro-B-type Natriuretic Peptide in the Serum of Patients with Pre-eclampsia and Its Clinical Significance

A clinical study of the brain natriuretic peptide in the diagnosis of myocardial injury after neonatal asphyxia

Change and Prognosis Prediction of N-terminal Pro-Brain Natriuretic Peptide in Neonates with Hypoxic-Ischemic Encephalopathy Complicated with Myocardial Ischemic Injury

The predictive value of N-terminal pro-brain natriuretic peptide on prognosis of sepsis

Prognostic value of N-terminal pro-brain natriuretic peptide in patients with sepsis

Serum N-terminal Pro-Brain Natriuretic Peptide Level is a Significant Prognostic Factor in Patients with Severe Sepsis among Southwest Chinese Population.

Association Between NT-proBNP and Prolonged Length of Stay in Hospital Among Preterm Infants Born at 28–31 Weeks' Gestation

[The Prognostic Value of N-terminal Pro-B-type Natriuretic Peptide in Patients with Severe Sepsis and Septic Shock].

Development of a Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia or Death: Role of N-Terminal Pro-brain Natriuretic Peptide as a Biomarker

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

Predictive value of plasma N-terminal-pro-brain natriuretic peptide in weaning patients from mechanical ventilation

Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China

Predictive Value of N-terminal Pro-B-type Natriuretie Peptide on Prognosis of Critically Ill Patients in Surgical Intensive Care Unit and Its Possible Influential Factors